Alogliptin – a new DPP‐4 inhibitor for type 2 diabetes. Issue 22 (19th November 2014)
- Record Type:
- Journal Article
- Title:
- Alogliptin – a new DPP‐4 inhibitor for type 2 diabetes. Issue 22 (19th November 2014)
- Main Title:
- Alogliptin – a new DPP‐4 inhibitor for type 2 diabetes
- Authors:
- Chaplin, Steve
Farooqi, Azhar - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Alogliptin (Vipidia), the latest DPP‐4 inhibitor, is licensed as second‐line therapy in patients with type 2 diabetes mellitus. Steve Chaplin presents the data relating to its efficacy and adverse events and Azhar Farooqi outlines its place in therapy.</p> </abstract>
- Is Part Of:
- Prescriber. Volume 25:Issue 22(2014:Nov.)
- Journal:
- Prescriber
- Issue:
- Volume 25:Issue 22(2014:Nov.)
- Issue Display:
- Volume 25, Issue 22 (2014)
- Year:
- 2014
- Volume:
- 25
- Issue:
- 22
- Issue Sort Value:
- 2014-0025-0022-0000
- Page Start:
- 15
- Page End:
- 16
- Publication Date:
- 2014-11-19
- Subjects:
- Chemotherapy -- Periodicals
Drugs -- Prescribing -- Periodicals
615.1 - Journal URLs:
- http://www.prescriber.co.uk/view/0/index.html ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/psb.1281 ↗
- Languages:
- English
- ISSNs:
- 0959-6682
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6609.700100
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 2990.xml